Over the last few decades, governments and businesses worldwide have been galvanized to address the threat of global warming. In December, 170 countries will meet in an attempt to pass the Copenhagen Protocol, the successor to 2005’s Kyoto Protocol. Set to expire in 2012, the Kyoto Protocol calls for a 5.2% yearly reduction in emissions […]
Since 2007 and the discovery of high amounts of lead in the paint on children’s toys (see IBO 11/15/07), handheld X-ray Fluorescence spectrometry (XRF) has attracted attention for its ability to quickly and easily screen for lead content in consumer products on site (see IBO 2/29/08). The US’s Consumer Product Safety Improvement Act of 2008 […]
The biotechnology research and production capabilities of the EU’s newest member states are stable and growing, according to a new report from the 14allbio project. Earlier this month, the 14allbio project, which is funded by the EU’s Sixth Framework Program, published a report prepared by the European Association for Bioindustries and Venture Valuation AG. “Biotech […]
Evidence that the EU-12 will continue to attract FDI, but at a lower rate, is provided by the annual United Nations Conference on Trade and Development’s (UNCTD) World Investments Prospects Survey (WIPS). Conducted between February and May, the WIPS is based on 241 responses and 20 interviews with executives at large, nonfinancial, transnational corporations. As […]
Despite extreme market volatility, the Dow Jones Industrial Average, S&P 500 and NASDAQ ended the month up 2.3%, 3.6% and 5.6%, respectively. For most of September, the US equity markets were bolstered by the declining US dollar and optimistic statements by the Federal Reserve. In addition, several economic indicators for August, such as industrial production, […]
The second of IBO’s biannual new laboratory roundup primarily focuses on pharmaceutical and biological research. Despite the effects of the global economic downturn, a number of new pharmaceutical and consumer goods testing labs have been announced or completed in China with both government and private support. In the US, although a number of private pharmaceutical […]
Man-Tech Associates, an early developer of automated titration systems, was founded in 1995 and is part of a group of companies that includes Man-Sci and Mandel Scientific. Total group revenues are around $20 million and the group has 80 employees. Man-Tech began as a venture to develop and commercialize software and robotics for titration. According […]
Agilent disclosed few additional details in its August 17 quarterly conference call about its agreement to acquire Varian for $1.5 billion (see IBO 7/31/09, 8/15/09). The $1.5 billion deal includes the purchase of outstanding common stock, cashing out of “in the money” stock options and assumed debt. Varian shareholders will vote on the merger agreement […]
Second-quarter 2009 IBO Life Science Index sales declined 4.3% to $2,336.48 million. Operating profit grew 5.9% to $404.34 million, and operating margin climbed 170 basis points to 17.3% of sales. Sales growth for a majority of companies was adversely affected by currency transactions and budget constraints. Operating profits benefited from restructuring activities. Second-quarter sales for […]
In the second acquisition worth over $1 billion in just over a month, Danaher has announced an agreement to acquire Life Technologies’ MS business and MDS Analytical Technologies for a combined price of $1.1 billion (see page 2). The deal brings a new player into the highly competitive MS market and enlarges Danaher’s presence in […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
